Marie Foley Kijewski, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Emission-Computed, Single-Photon | 20 | 2020 | 1145 | 1.620 |
Why?
|
Amyloidosis | 11 | 2023 | 885 | 1.470 |
Why?
|
Cardiomyopathies | 12 | 2024 | 2067 | 0.940 |
Why?
|
Ethylene Glycols | 6 | 2024 | 196 | 0.780 |
Why?
|
Radiopharmaceuticals | 13 | 2024 | 2699 | 0.730 |
Why?
|
Aniline Compounds | 6 | 2024 | 1075 | 0.580 |
Why?
|
Positron-Emission Tomography | 14 | 2024 | 6546 | 0.530 |
Why?
|
Fluorine Radioisotopes | 4 | 2020 | 397 | 0.530 |
Why?
|
Image Enhancement | 5 | 2013 | 2859 | 0.510 |
Why?
|
Technetium Tc 99m Pyrophosphate | 4 | 2024 | 54 | 0.480 |
Why?
|
Myocardium | 9 | 2024 | 4763 | 0.440 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2024 | 187 | 0.380 |
Why?
|
Amyloid | 4 | 2023 | 853 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2020 | 8926 | 0.310 |
Why?
|
Corpus Striatum | 1 | 2013 | 1218 | 0.270 |
Why?
|
Technetium Tc 99m Exametazime | 4 | 2004 | 61 | 0.270 |
Why?
|
Prealbumin | 4 | 2024 | 266 | 0.270 |
Why?
|
Magnetic Resonance Imaging, Cine | 4 | 2024 | 1094 | 0.260 |
Why?
|
Heart | 5 | 2020 | 4417 | 0.250 |
Why?
|
Whole Body Imaging | 1 | 2007 | 281 | 0.250 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15390 | 0.230 |
Why?
|
Heart Failure | 4 | 2024 | 11840 | 0.220 |
Why?
|
Putamen | 2 | 2022 | 289 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2024 | 0.220 |
Why?
|
Phantoms, Imaging | 9 | 2022 | 2475 | 0.210 |
Why?
|
Tellurium | 2 | 2020 | 24 | 0.210 |
Why?
|
Ammonia | 1 | 2023 | 244 | 0.200 |
Why?
|
Brain | 11 | 2019 | 27178 | 0.200 |
Why?
|
Contrast Media | 3 | 2021 | 5326 | 0.190 |
Why?
|
Multiple Sclerosis | 4 | 2024 | 3213 | 0.190 |
Why?
|
Ventricular Function, Left | 4 | 2024 | 3930 | 0.190 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 40 | 0.190 |
Why?
|
Equipment Failure Analysis | 3 | 2013 | 834 | 0.190 |
Why?
|
Gallium Radioisotopes | 1 | 2002 | 195 | 0.190 |
Why?
|
Pyruvates | 1 | 2021 | 84 | 0.190 |
Why?
|
Cadmium | 2 | 2020 | 218 | 0.180 |
Why?
|
Molecular Imaging | 3 | 2023 | 822 | 0.180 |
Why?
|
Sensitivity and Specificity | 13 | 2013 | 14637 | 0.170 |
Why?
|
Mesencephalon | 1 | 2022 | 338 | 0.170 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2019 | 24 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2011 | 3359 | 0.160 |
Why?
|
Monte Carlo Method | 7 | 2012 | 1238 | 0.160 |
Why?
|
Thorax | 1 | 2002 | 553 | 0.160 |
Why?
|
Pyrrolidines | 1 | 2001 | 337 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1736 | 0.160 |
Why?
|
Substantia Nigra | 1 | 2020 | 346 | 0.150 |
Why?
|
Zinc | 2 | 2020 | 675 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 645 | 0.150 |
Why?
|
Equipment Design | 4 | 2013 | 3485 | 0.150 |
Why?
|
Neuroglia | 1 | 2024 | 964 | 0.150 |
Why?
|
Reproducibility of Results | 13 | 2023 | 20120 | 0.150 |
Why?
|
Encephalitis | 1 | 2022 | 440 | 0.150 |
Why?
|
Computer Simulation | 7 | 2012 | 6252 | 0.140 |
Why?
|
Algorithms | 9 | 2012 | 14061 | 0.140 |
Why?
|
Iodine Radioisotopes | 2 | 2001 | 1027 | 0.140 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 403 | 0.130 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 253 | 0.130 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 429 | 0.130 |
Why?
|
Benzamides | 2 | 2007 | 1376 | 0.130 |
Why?
|
Abdomen | 1 | 2002 | 1133 | 0.130 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 206 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 899 | 0.130 |
Why?
|
Photons | 3 | 2012 | 572 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2019 | 746 | 0.130 |
Why?
|
Hydrogen Peroxide | 1 | 2019 | 743 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2019 | 900 | 0.120 |
Why?
|
Peptide Fragments | 2 | 2024 | 5125 | 0.120 |
Why?
|
Tyrosine | 1 | 2018 | 1427 | 0.110 |
Why?
|
Organotechnetium Compounds | 3 | 2020 | 134 | 0.110 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 550 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 920 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 11 | 2024 | 36537 | 0.110 |
Why?
|
Immunoglobulin Light Chains | 2 | 2024 | 290 | 0.110 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2019 | 844 | 0.110 |
Why?
|
Humans | 56 | 2024 | 765734 | 0.100 |
Why?
|
Fatigue | 1 | 2020 | 1550 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 869 | 0.100 |
Why?
|
Models, Statistical | 2 | 2012 | 5088 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2880 | 0.090 |
Why?
|
Microglia | 1 | 2020 | 1371 | 0.090 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1670 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1036 | 0.090 |
Why?
|
Middle Aged | 23 | 2024 | 222903 | 0.090 |
Why?
|
Alzheimer Disease | 5 | 2022 | 8727 | 0.080 |
Why?
|
Aged | 21 | 2024 | 171050 | 0.080 |
Why?
|
Body Mass Index | 1 | 2007 | 13044 | 0.080 |
Why?
|
Male | 29 | 2024 | 363585 | 0.080 |
Why?
|
Normal Distribution | 2 | 2012 | 267 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2022 | 5768 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2046 | 0.080 |
Why?
|
Female | 28 | 2024 | 395961 | 0.070 |
Why?
|
Acetanilides | 2 | 2020 | 167 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2019 | 3140 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2350 | 0.070 |
Why?
|
Tomography, Emission-Computed | 3 | 1988 | 1006 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1530 | 0.070 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 669 | 0.070 |
Why?
|
Tropanes | 1 | 2005 | 47 | 0.060 |
Why?
|
Neoplasms | 3 | 2011 | 22345 | 0.060 |
Why?
|
Coronary Artery Disease | 3 | 2019 | 6545 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2820 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 979 | 0.060 |
Why?
|
Rubidium Radioisotopes | 1 | 2005 | 101 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3670 | 0.060 |
Why?
|
Calibration | 2 | 1997 | 814 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5596 | 0.060 |
Why?
|
Radionuclide Imaging | 3 | 2018 | 1978 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8626 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10846 | 0.060 |
Why?
|
Multiple System Atrophy | 1 | 2005 | 132 | 0.060 |
Why?
|
Glioblastoma | 1 | 2018 | 3459 | 0.050 |
Why?
|
Computer-Aided Design | 1 | 2005 | 291 | 0.050 |
Why?
|
Likelihood Functions | 2 | 2005 | 993 | 0.050 |
Why?
|
Prospective Studies | 6 | 2024 | 54795 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20667 | 0.050 |
Why?
|
Artifacts | 1 | 2011 | 1893 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2019 | 3425 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13462 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2023 | 153 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2023 | 5302 | 0.050 |
Why?
|
Models, Theoretical | 4 | 2005 | 3563 | 0.050 |
Why?
|
Heart Ventricles | 2 | 2024 | 3831 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2007 | 616 | 0.050 |
Why?
|
Pyrimidines | 2 | 2018 | 3044 | 0.050 |
Why?
|
Stochastic Processes | 1 | 2002 | 358 | 0.050 |
Why?
|
Cysteine | 1 | 2005 | 898 | 0.040 |
Why?
|
Pilot Projects | 3 | 2023 | 8732 | 0.040 |
Why?
|
Heart Transplantation | 2 | 2024 | 3310 | 0.040 |
Why?
|
Diphosphates | 1 | 2020 | 91 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9368 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2473 | 0.040 |
Why?
|
Scattering, Radiation | 2 | 2001 | 482 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2005 | 979 | 0.040 |
Why?
|
Quality Control | 1 | 2002 | 835 | 0.040 |
Why?
|
Parkinson Disease | 2 | 2005 | 2891 | 0.040 |
Why?
|
Echocardiography | 2 | 2024 | 5044 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2349 | 0.040 |
Why?
|
Fluoroacetates | 1 | 2018 | 13 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2018 | 134 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1407 | 0.040 |
Why?
|
Finland | 1 | 2019 | 608 | 0.040 |
Why?
|
Coronary Circulation | 1 | 2024 | 1602 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2018 | 9071 | 0.040 |
Why?
|
Motion | 1 | 2022 | 781 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 177 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 359 | 0.040 |
Why?
|
Gamma Cameras | 1 | 1997 | 35 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14745 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2019 | 227 | 0.040 |
Why?
|
Death Certificates | 1 | 2018 | 170 | 0.040 |
Why?
|
Radiotherapy | 1 | 1984 | 1494 | 0.040 |
Why?
|
Piperazines | 1 | 2007 | 2546 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1377 | 0.030 |
Why?
|
Time Factors | 3 | 2024 | 40066 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15883 | 0.030 |
Why?
|
Choline | 1 | 2018 | 511 | 0.030 |
Why?
|
Neprilysin | 1 | 2019 | 484 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2068 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2019 | 491 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2001 | 751 | 0.030 |
Why?
|
Prognosis | 3 | 2024 | 29899 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1884 | 0.030 |
Why?
|
Adult | 9 | 2024 | 222974 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18289 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2019 | 1885 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59459 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1185 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2266 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4036 | 0.030 |
Why?
|
Troponin T | 1 | 2019 | 785 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 1020 | 0.030 |
Why?
|
Dependovirus | 1 | 2019 | 721 | 0.030 |
Why?
|
Cerebellum | 1 | 2001 | 1519 | 0.030 |
Why?
|
Cerebrovascular Circulation | 2 | 2001 | 2673 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2409 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2112 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2075 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3605 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2859 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1869 | 0.020 |
Why?
|
Nuclear Medicine | 1 | 1995 | 261 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1273 | 0.020 |
Why?
|
Lyme Disease | 1 | 1997 | 627 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2012 | 508 | 0.020 |
Why?
|
Dementia | 1 | 2004 | 2745 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1892 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2019 | 3404 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8528 | 0.020 |
Why?
|
Animals | 5 | 2021 | 168731 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2918 | 0.020 |
Why?
|
Brain Diseases | 1 | 1997 | 1550 | 0.020 |
Why?
|
Bone and Bones | 1 | 2018 | 2554 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2891 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5787 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7066 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3709 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6754 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74831 | 0.020 |
Why?
|
Radiography | 2 | 2011 | 6917 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1880 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81792 | 0.020 |
Why?
|
Electroencephalography | 1 | 2022 | 6275 | 0.020 |
Why?
|
Models, Biological | 1 | 2002 | 9441 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9548 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10428 | 0.020 |
Why?
|
Software | 1 | 2019 | 4459 | 0.010 |
Why?
|
Analog-Digital Conversion | 1 | 1984 | 23 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11007 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17062 | 0.010 |
Why?
|
Brain Ischemia | 1 | 1997 | 3000 | 0.010 |
Why?
|
United States | 3 | 2020 | 72898 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59852 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14445 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9511 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41631 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18972 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24279 | 0.010 |
Why?
|
Technology, Radiologic | 1 | 1983 | 158 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23704 | 0.010 |
Why?
|
Mathematics | 2 | 1995 | 696 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2024 | 65180 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10031 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39180 | 0.010 |
Why?
|
Bayes Theorem | 2 | 2001 | 2354 | 0.010 |
Why?
|
Biophysical Phenomena | 1 | 2001 | 318 | 0.010 |
Why?
|
Biophysics | 1 | 2001 | 375 | 0.010 |
Why?
|
Patient Care Planning | 1 | 1984 | 906 | 0.010 |
Why?
|
Ceftriaxone | 1 | 1997 | 176 | 0.010 |
Why?
|
Cephalosporins | 1 | 1997 | 200 | 0.010 |
Why?
|
Memory Disorders | 1 | 2003 | 1193 | 0.010 |
Why?
|
Tungsten | 1 | 1995 | 18 | 0.010 |
Why?
|
Aging | 1 | 1993 | 8730 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88781 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 81457 | 0.010 |
Why?
|
Oximes | 1 | 1993 | 305 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3805 | 0.010 |
Why?
|
Reference Values | 1 | 1997 | 4909 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12949 | 0.010 |
Why?
|
Observer Variation | 1 | 1995 | 2611 | 0.000 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1986 | 51 | 0.000 |
Why?
|
Amphetamines | 1 | 1986 | 143 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13639 | 0.000 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1988 | 1456 | 0.000 |
Why?
|
ROC Curve | 1 | 1988 | 3618 | 0.000 |
Why?
|
Cerebrovascular Disorders | 1 | 1986 | 1470 | 0.000 |
Why?
|
Mental Disorders | 1 | 1997 | 6869 | 0.000 |
Why?
|